Skip to main content

JANE STREET GROUP, LLC

Position in ENGN — enGene Therapeutics Inc.

CIK 1595888 NEW YORK, NY

Position in ENGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$661,653
-$400,713 QoQ
Shares Held
382,459
+145.2% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 60 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Derivatives in ENGN

reported options exposure · as of Jun 30, 2026
CallValue
$32,870
CallShares
19,000
PutValue
$94,804
PutShares
54,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,862,981 across 291 Biotechnology names. ENGN ranks #99 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $94,804 54,800
2026-06-30 $32,870 19,000
2026-06-30 $661,653 382,459
2026-03-31 $1,062,366 156,001
2025-12-31 $509,779 56,454
2024-12-31 $93,352 14,038